These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3929526)

  • 1. [A case of factor VIIICAg-positive severe hemophilia A with factor VIII inhibitor].
    Shima M; Imai S; Tsubura Y; Yoshioka A; Tsukada S; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1985 May; 48(3):843-8. PubMed ID: 3929526
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of factor VIII-coagulation antigen in factor VIII concentrates using an inhibitor test].
    Im T; Hintz G
    Arzneimittelforschung; 1986; 36(1):124-6. PubMed ID: 3082340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII clotting antigen (VIIICAg) in haemophilia measured by two immunoradiometric assays (IRMA) using different antibodies, and the measurement of inhibitors to procoagulant factor VIII (VIIIC) by IRMA.
    Furlong RA; Peake IR; Bloom AL
    Br J Haematol; 1981 Aug; 48(4):643-50. PubMed ID: 6791678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitors and "bypass" therapy in hemophilia].
    Fukutake K; Fukutake K
    Nihon Rinsho; 1981; 39(12):3688-99. PubMed ID: 6803034
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phospholipid on factor VIII inactivation.
    Barrowcliffe TW; Kemball-Cook G; Gray E
    Prog Clin Biol Res; 1984; 150():251-63. PubMed ID: 6431431
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIII.
    Kreuz W; Becker S; Lenz E; Martinez-Saguer I; Escuriola-Ettingshausen C; Funk M; Ehrenforth S; Auerswald G; Kornhuber B
    Semin Thromb Hemost; 1995; 21(4):382-9. PubMed ID: 8747701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factor VIII, factor VIII inhibitor].
    Takamatsu J
    Nihon Rinsho; 1999 Sep; 57 Suppl():604-6. PubMed ID: 10543190
    [No Abstract]   [Full Text] [Related]  

  • 10. [Factor VIII inhibitor-caused hemophilia].
    Peto I; Bánhegyi D; Nemesánszky E; Köves A; Sas G
    Orv Hetil; 1977 Sep; 118(36):2145-9. PubMed ID: 917507
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of coagulation factor VIII inhibitors].
    Lutze G; Schlote A; Mittler U
    Z Gesamte Inn Med; 1980 Apr; 35(8):330-6. PubMed ID: 6776700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic factor VIII inhibitor autoantibody in a man presented after accident.
    Mansouritorghabeh H; Lak M; van Heerde WL
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):588-90. PubMed ID: 18550586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of proteolytic antibodies against factor VIII in hemophilia A.
    Lacroix-Desmazes S; Bayry J; Misra N; Horn MP; Villard S; Pashov A; Stieltjes N; d'Oiron R; Saint-Remy JM; Hoebeke J; Kazatchkine MD; Reinbolt J; Mohanty D; Kaveri SV
    N Engl J Med; 2002 Feb; 346(9):662-7. PubMed ID: 11870243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemophiliacs with inhibitor. Experience at the Center of Medical Action for Hemophilia of the S. José Hospital].
    Diniz MJ; Dias Francisco F; Tavares ML; Leal I
    Acta Med Port; 1992 Apr; 5(4):178-80. PubMed ID: 1605065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factor VIII inhibitor in a patient with mild haemophilia A (author's transl)].
    Gastaldi G; Avanzi G; Saccon C; Galletti A
    Haematologica; 1975 Dec; 60(4):477-84. PubMed ID: 816717
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitor to factor VIII in mild haemophilia.
    Kesteven PJ; Holland LJ; Lawrie AS; Savidge GF
    Thromb Haemost; 1984 Aug; 52(1):50-2. PubMed ID: 6437010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin.
    Santagostino E; Gringeri A; Tagliavacca L; Mannucci PM
    Thromb Haemost; 1995 Aug; 74(2):619-21. PubMed ID: 8584995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case with an inhibitor against factor VIII activity after the second postpartum].
    Shinohara K; Sasaki H; Yamada K; Ishida Y; Kaneko T; Matsumoto N
    Rinsho Ketsueki; 1983 Dec; 24(12):1670-3. PubMed ID: 6423861
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM; Ludlam CA
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia A patients with factor VIII inhibitor.
    Sugihara T; Takahashi I; Kojima T; Okamoto Y; Yamamoto K; Kamiya T; Matsushita T; Saito H
    Nagoya J Med Sci; 2000 May; 63(1-2):25-39. PubMed ID: 10911718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.